2019.11.28
License Agreement Has Been Entered into with Aspen Neuroscience, Inc.
License-Out
We have executed a worldwide license agreement with Aspen Neuroscience, Inc. (San Diego, U.S.A) for the use of iPS cell-derived dopamine neuron products for regenerative therapy under the patents on iPS cell related technologies licensed to us by Kyoto University.